Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump. Supplementary Tables
posted on 2022-09-21, 08:05authored byMikhail A Rojavin, Michaela Praus, Eileen Rogers, Fiona Glassman, Jutta Hofmann, Niraj C Patel, Michael J. Palumbo, Patricia L. Lugar, John Anderson, Charlotte Cunningham-Rundles, Richard L. Wasserman
Supplementary Table 1.
Median weekly dose levels for patients administering IgPro20 with the IWI and CP.
*Patient numbers differed for this row: Sequence 1 (CP/IWI): N=10; Sequence 2 (IWI/CP): N=12; Total: N=22